Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
OPN-7486
i
Other names:
PLX7486, PLX 7486, PLX-7486, PLX7486-TsOH, OPN-7486
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Opna Bio
Drug class:
CSF-1R inhibitor, FMS kinase inhibitor
Related drugs:
‹
avapritinib (13)
TPX-0022 (8)
pexidartinib (6)
pacritinib (3)
vorolanib (1)
BMS-986227 (1)
CS 2164 (1)
ABSK021 (1)
AMB-05X (0)
C019199 (0)
HH185 (0)
LY3022855 (0)
NMS-088 (0)
SU 14813 (0)
SYHA1813 (0)
Q702 (0)
SNDX-6352 (0)
SYHA1817 (0)
BLZ-945 (0)
DCC-3014 (0)
avapritinib (13)
TPX-0022 (8)
pexidartinib (6)
pacritinib (3)
vorolanib (1)
BMS-986227 (1)
CS 2164 (1)
ABSK021 (1)
AMB-05X (0)
C019199 (0)
HH185 (0)
LY3022855 (0)
NMS-088 (0)
SU 14813 (0)
SYHA1813 (0)
Q702 (0)
SNDX-6352 (0)
SYHA1817 (0)
BLZ-945 (0)
DCC-3014 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
ETV6-NTRK3 fusion
Acute Lymphocytic Leukemia
ETV6-NTRK3 fusion
Acute Lymphocytic Leukemia
OPN-7486
Sensitive: D – Preclinical
OPN-7486
Sensitive
:
D
OPN-7486
Sensitive: D – Preclinical
OPN-7486
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login